Karthik Radhakrishnan - Chief Financial Officer at Monopar Therapeutics

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
MNPR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Karthik Radhakrishnan since 12 Feb 2025

Holdings reported by Karthik Radhakrishnan for Monopar Therapeutics

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,550 $10,447 $6.74 28 Oct 2024 Direct
Stock Options 125,000 01 Jul 2024 Direct Commom Stock

Transactions reported by Karthik Radhakrishnan for Monopar Therapeutics

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.